UNIQURE NV's ticker is QURE and the CUSIP is N90064101. A total of 162 filers reported holding UNIQURE NV in Q3 2020. The put-call ratio across all filers is 0.22 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2020 | $213,000 | -4.9% | 4,717 | 0.0% | 0.00% | – |
Q1 2020 | $224,000 | -62.9% | 4,717 | -44.0% | 0.00% | -100.0% |
Q4 2019 | $604,000 | +153.8% | 8,425 | +39.1% | 0.00% | – |
Q3 2019 | $238,000 | -38.7% | 6,056 | +22.1% | 0.00% | – |
Q2 2019 | $388,000 | +31.1% | 4,960 | 0.0% | 0.00% | – |
Q1 2019 | $296,000 | -16.6% | 4,960 | -76.9% | 0.00% | -100.0% |
Q4 2015 | $355,000 | -18.9% | 21,439 | 0.0% | 0.00% | 0.0% |
Q3 2015 | $438,000 | -24.4% | 21,439 | 0.0% | 0.00% | 0.0% |
Q2 2015 | $579,000 | +11.1% | 21,439 | 0.0% | 0.00% | 0.0% |
Q1 2015 | $521,000 | – | 21,439 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 155,500 | $11,803,000 | 2.66% |
Aquilo Capital Management, LLC | 901,490 | $16,290,000 | 2.39% |
Nantahala Capital Management | 2,811,459 | $50,803,000 | 2.25% |
Privium Fund Management B.V. | 493,229 | $8,913,000 | 1.97% |
683 Capital Management, LLC | 1,355,000 | $24,485,000 | 1.31% |
Henry James International Management Inc. | 125,622 | $2,270,000 | 0.90% |
Integral Health Asset Management, LLC | 170,000 | $3,072,000 | 0.80% |
Nantahala Capital Management | 890,000 | $16,082,000 | 0.71% |
Sonic Fund II, L.P. | 50,000 | $904,000 | 0.51% |
Voss Capital, LLC | 70,000 | $1,265,000 | 0.40% |